@soaringtothestars's peptide stack claims, fact-checked
Quick answer
MOTS-C is an experimental mitochondrial peptide with limited mouse studies and no human athletic performance trials. NAD supplementation has mixed evidence for exercise benefits, while "Klow" appears to be non-existent in legitimate peptide research.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
Joseph Rinoza Plazo's Instagram post about peptides for running performance makes some bold claims about MOTS-C, "Klow," and NAD enhancing endurance and recovery. Most of these substances have limited human evidence, and some don't exist in commercial peptide therapy.
What does this video actually claim?
Plazo promotes three substances for marathon performance: MOTS-C for endurance, "Klow" for resilience, and NAD for what he calls "cellular fire." He frames these not as shortcuts but as signals that remind your body "who it used to be."
The post suggests these peptides can help runners recover smarter and perform better. He directs followers to check with @rtauro_209 for "legit sources" but doesn't cite any specific studies himself.
The language is motivational rather than medical, but the implied claims about performance enhancement are clear.
Do these peptides actually work for runners?
The evidence is thin to nonexistent for most of these claims. MOTS-C (mitochondrial-derived peptide) has shown some promise in mouse studies for exercise capacity, but human data is extremely limited.
A 2021 study by Reynolds et al. in Nature Communications found MOTS-C improved exercise capacity in aged mice, but no published trials have tested it in human athletes. The peptide isn't even approved by the FDA for any use.
"Klow" appears to be entirely fictional or a brand name not found in any peptide research databases. NAD (nicotinamide adenine dinucleotide) supplements have mixed results, with some studies showing minimal benefit for athletic performance.
What did he get wrong?
The biggest problem is presenting experimental substances as proven performance enhancers. MOTS-C research is preliminary at best, and "Klow" doesn't seem to exist in legitimate peptide literature.
The phrase about peptides "reminding your body who it used to be" is marketing speak without scientific basis. Peptide therapy doesn't work through cellular memory or nostalgia.
Directing people to an Instagram account for "legit sources" instead of peer-reviewed research is also questionable. Real scientific evidence doesn't typically come through social media referrals.
What should runners actually know about peptides?
Most peptides marketed for athletic performance lack strong human studies. The few that show promise, like BPC-157 for injury recovery, still need more research before recommendations can be made.
Legal peptides for performance are limited. Growth hormone releasing peptides like CJC-1295 and ipamorelin have some research, but they're not approved for athletic enhancement and carry potential side effects.
Runners looking for proven performance aids should focus on established methods: proper training, nutrition, sleep, and recovery protocols that actually have decades of research behind them.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
NAD+ Peptide Complex access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @soaringtothestars's peptide stack claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
Foundational preclinical study (Cell Metabolism) where MOTS-c prevented diet-induced obesity and insulin resistance in mice; no human data.
PubMed
MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism
Review summarizing MOTS-c metabolic effects drawn from rodent and cell studies, not human trials.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
NAD+ Peptide Complex should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this nad+ video claims cluster
Best for searchers separating NAD+ longevity marketing from practical metabolic and safety questions.
Claim verdict
The useful answer behind this video
Claim being checked
MOTS-C is an experimental mitochondrial peptide with limited mouse studies and no human athletic performance trials.
FormBlends verdict
MOTS-C is an experimental mitochondrial peptide with limited mouse studies and no human athletic performance trials. NAD supplementation has mixed evidence for exercise benefits, while "Klow" appears to be non-existent in legitimate peptide research.
Patient-safe next step
Compare the claim with the NAD+ Peptide Complex guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MOTS-C is an experimental mitochondrial peptide with limited mouse studies and no human athletic performance trials. NAD supplementation has mixed evidence for exercise benefits, while "Klow" appears to be non-existent in legitimate peptide research.
- MOTS-C has only been tested in mice, not human athletes, despite claims about endurance benefits
- "Klow" doesn't appear in any legitimate peptide research or commercial databases
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- NAD+ Peptide Complex decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the NAD+ Peptide Complex guide, cost path, safety notes, and provider review before acting.
Review NAD+ Peptide ComplexWhat You'll Learn
- MOTS-C has only been tested in mice, not human athletes, despite claims about endurance benefits
- "Klow" doesn't appear in any legitimate peptide research or commercial databases
- NAD supplementation has mixed evidence for athletic performance in published studies
- Most peptides marketed for sports performance lack strong human clinical trials
- FDA hasn't approved these specific peptides for athletic enhancement or recovery
- Proven performance aids for runners include training, nutrition, and sleep optimization
- Social media accounts aren't reliable sources for peptide safety and efficacy data
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Joseph Rinoza Plazo · Instagram creator
29.5K views on this video
Pumped for my first run of the year - the Cebu Sinulog with Runette. Run faster. Recover smarter. Dream bigger. 🏃♂️✨ MOTS-C for endurance, Klow for resilience, NAD for cellular fire—not shortcuts, b
Not medical advice. This video was made by Joseph Rinoza Plazo, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.